ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $280 | -99.9% | 2,995 | +69.1% | 0.03% | +86.7% |
Q1 2022 | $208,000 | -56.6% | 1,771 | -50.2% | 0.02% | -69.4% |
Q4 2021 | $479,000 | +116.7% | 3,558 | +111.5% | 0.05% | +133.3% |
Q2 2021 | $221,000 | -19.9% | 1,682 | -5.9% | 0.02% | -55.3% |
Q3 2020 | $276,000 | -56.3% | 1,787 | -67.4% | 0.05% | +27.0% |
Q2 2019 | $631,000 | +173.2% | 5,483 | +179.2% | 0.04% | +184.6% |
Q1 2019 | $231,000 | +1.8% | 1,964 | -43.5% | 0.01% | +8.3% |
Q1 2018 | $227,000 | – | 3,478 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 10,719,555 | $1,003,779,130 | 19.76% |
Q Global Advisors, LLC | 285,000 | $26,687 | 17.16% |
Finepoint Capital LP | 163,772 | $15,335,610 | 7.64% |
Avoro Capital Advisors LLC | 3,670,000 | $343,658,800 | 5.36% |
Spyglass Capital Management LLC | 614,618 | $57,552,830 | 4.51% |
Sofinnova Investments, Inc. | 754,032 | $70,607,556 | 4.45% |
Saturn V Capital Management LP | 112,473 | $10,531,972 | 4.41% |
DAFNA Capital Management LLC | 136,212 | $12,754,892 | 3.97% |
ARS Investment Partners, LLC | 285,918 | $26,773,362 | 3.32% |
Ghost Tree Capital, LLC | 85,000 | $7,959,400 | 2.62% |